Department of General, Visceral, and Transplantation Surgery, University Hospital Heidelberg, Im Neuenheimer Feld 420, 69120, Heidelberg, Germany.
Department of Gastroenterology, Digestive Oncology Unit, Champalimaud Foundation, Lisbon, Portugal.
Surg Endosc. 2022 Jun;36(6):3708-3720. doi: 10.1007/s00464-022-09137-6. Epub 2022 Mar 4.
The outcomes of endoscopic ultrasonography-guided drainage (EUSD) in treatment of pancreas fluid collection (PFC) after pancreas surgeries have not been evaluated systematically. The current systematic review and meta-analysis aim to evaluate the outcomes of EUSD in patients with PFC after pancreas surgery and compare it with percutaneous drainage (PCD).
PubMed and Web of Science databases were searched for studies reporting outcomes EUSD in treatment of PFC after pancreas surgeries, from their inception until January 2022. Two meta-analyses were performed: (A) a systematic review and single-arm meta-analysis of EUSD (meta-analysis A) and (B) two-arm meta-analysis comparing the outcomes of EUSD and PCD (meta-analysis B). Pooled proportion of the outcomes in meta-analysis A as well as odds ratio (OR) and mean difference (MD) in meta-analysis B was calculated to determine the technical and clinical success rates, complications rate, hospital stay, and recurrence rate. ROBINS-I tool was used to assess the risk of bias.
The literature search retrieved 610 articles, 25 of which were eligible for inclusion. Included clinical studies comprised reports on 695 patients. Twenty-five studies (477 patients) were included in meta-analysis A and eight studies (356 patients) were included in meta-analysis B. In meta-analysis A, the technical and clinical success rates of EUSD were 94% and 87%, respectively, with post-procedural complications of 14% and recurrence rates of 9%. Meta-analysis B showed comparable technical and clinical success rates as well as complications rates between EUSD and PCD. EUSD showed significantly shorter duration of hospital stay compared to that of patients treated with PCD.
EUSD seems to be associated with high technical and clinical success rates, with low rates of procedure-related complications. Although EUSD leads to shorter hospital stay compared to PCD, the certainty of evidence was low in this regard.
内镜超声引导下引流(EUSD)治疗胰腺手术后胰腺液体积聚(PFC)的效果尚未得到系统评价。本系统评价和荟萃分析旨在评估 EUSD 治疗胰腺手术后 PFC 的效果,并将其与经皮引流(PCD)进行比较。
检索 PubMed 和 Web of Science 数据库,检索时间从建库至 2022 年 1 月,收集关于 EUSD 治疗胰腺手术后 PFC 的研究。进行了两项荟萃分析:(A)EUSD 的系统评价和单臂荟萃分析(荟萃分析 A)和(B)比较 EUSD 和 PCD 治疗效果的双臂荟萃分析(荟萃分析 B)。荟萃分析 A 中汇总结局的比例以及荟萃分析 B 中比值比(OR)和均数差(MD)用于确定技术和临床成功率、并发症发生率、住院时间和复发率。使用 ROBINS-I 工具评估偏倚风险。
文献检索共检索到 610 篇文章,其中 25 篇符合纳入标准。纳入的临床研究报告了 695 例患者。荟萃分析 A 纳入 25 项研究(477 例患者),荟萃分析 B 纳入 8 项研究(356 例患者)。荟萃分析 A 中,EUSD 的技术和临床成功率分别为 94%和 87%,术后并发症发生率为 14%,复发率为 9%。荟萃分析 B 显示 EUSD 与 PCD 的技术和临床成功率以及并发症发生率相当。EUSD 组患者的住院时间明显短于 PCD 组。
EUSD 似乎与较高的技术和临床成功率相关,并发症发生率较低。尽管 EUSD 与 PCD 相比可缩短住院时间,但这方面的证据确定性较低。